Opinion|Videos|August 15, 2023

CheckMate 9ER Trial Updates

Centering discussion on the CheckMate 9ER trial, Dr. McKay shares perspective of recent follow-up data of nivolumab + cabozantinib in frontline advanced RCC.


Latest CME